Viewing Study NCT03064867


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-01-11 @ 1:44 AM
Study NCT ID: NCT03064867
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-11-16
First Post: 2017-02-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Molly Gallogly
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module